Literature DB >> 27442980

Health-related quality of life of primary care patients with depressive disorders.

K Riihimäki1, H Sintonen2, M Vuorilehto3, P Jylhä3, S Saarni4, E Isometsä5.   

Abstract

BACKGROUND: Depressive disorders are known to impair health-related quality of life (HRQoL) both in the short and long term. However, the determinants of long-term HRQoL outcomes in primary care patients with depressive disorders remain unclear.
METHODS: In a primary care cohort study of patients with depressive disorders, 82% of 137 patients were prospectively followed up for five years. Psychiatric disorders were diagnosed with SCID-I/P and SCID-II interviews; clinical, psychosocial and socio-economic factors were investigated by rating scales and questionnaires plus medical and psychiatric records. HRQoL was measured with the generic 15D instrument at baseline and five years, and compared with an age-standardized general population sample (n=3707) at five years.
RESULTS: Depression affected the 15D total score and almost all dimensions at both time points. At the end of follow-up, HRQoL of patients in major depressive episode (MDE) was particularly low, and the association between severity of depression (Beck Depression Inventory [BDI]) and HRQoL was very strong (r=-0.804). The most significant predictors for change in HRQoL were changes in BDI and Beck Anxiety Inventory (BAI) scores. The mean 15D score of depressive primary care patients at five years was much worse than in the age-standardized general population, reaching normal range only among patients who were in clinical remission and had virtually no symptoms.
CONCLUSIONS: Among depressive primary care patients, presence of current depressive symptoms markedly reduces HRQoL, with symptoms of concurrent anxiety also having a marked impact. For HRQoL to normalize, current depressive and anxiety symptoms must be virtually absent.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Comorbidity; Depression; Follow-up; Health-related quality of life; Primary care

Mesh:

Year:  2016        PMID: 27442980     DOI: 10.1016/j.eurpsy.2016.04.008

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  5 in total

1.  Trajectories of generalized anxiety disorder, major depression and change in quality of life in adults aged 50 + : findings from a longitudinal analysis using representative, population-based data from Ireland.

Authors:  Johanna Katharina Hohls; Hans-Helmut König; André Hajek
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-10-13       Impact factor: 4.519

2.  Patients with Hidradenitis Suppurativa Suffer from Low Health-Related Quality of Life as Measured by the Generic 15D Instrument.

Authors:  Mirkka J Hirvonen; Rafael Pasternack; Tiina Lipitsä; Armi Vihervaara; Rauno Harvima; Martta Ranta; Harri Sintonen; Laura Huilaja
Journal:  Skin Appendage Disord       Date:  2021-12-27

3.  Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trial.

Authors:  Claudi Bockting; Amanda M Legemaat; Johanne G J van der Stappen; Gert J Geurtsen; Maria Semkovska; Huibert Burger; Isidoor O Bergfeld; Nicoline Lous; Damiaan A J P Denys; Marlies Brouwer
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

4.  Long-term outcomes in patients with severe depression after in-hospital treatment - study protocol of the depression long-term Augsburg (DELTA) study.

Authors:  Inge Kirchberger; Barbara Maleckar; Christine Meisinger; Jakob Linseisen; Max Schmauss; Jessica Baumgärtner
Journal:  BMJ Open       Date:  2019-12-23       Impact factor: 2.692

5.  Well-being in major depression and social phobia with and without comorbidity.

Authors:  Hanna Wersebe; Roselind Lieb; Andrea H Meyer; Marcel Miche; Thorsten Mikoteit; Christian Imboden; Jürgen Hoyer; Klaus Bader; Martin Hatzinger; Andrew T Gloster
Journal:  Int J Clin Health Psychol       Date:  2018-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.